Skip to main content
. 2022 Apr 19;15(5):495. doi: 10.3390/ph15050495

Figure 6.

Figure 6

PPARγ immunoreactivity in extrahippocampal regions of controls and rats treated with cannabidiol (CBD) or with medium-chain triglyceride (MCT) oil. Non-treated controls (CTRL NT, n = 6) and epileptic animals (A) treated with CBD at high dose (CBD 120, n = 6), CBD at low dose (CBD 12, n = 6), or MCT oil (MCT OIL, n = 6) were used to determine the levels of PPARγ in lateral amygdala (La) (B), and perirhinal cortex (PRh) (C). * p < 0.05, CBD 120 vs. CTRL NT; Holm-Šidák test. Scale: 0.1 mm.